查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1477068

全球肿瘤栓塞器材市场：到 2033 年的机会与策略

Tumor Embolization Devices Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 281 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2018年全球肿瘤栓塞器械市场价值为11.4318亿美元，到2023年复合年增长率将超过4.0%。

研发支出增加

迄今为止，医疗领域不断上涨的研发费用推动了肿瘤栓塞器材市场的发展。研发支出的增加将有助于探索肿瘤栓塞装置的新型材料和设计。其结果是开发出更有效率、更有效的设备，从而可以更好地治疗肿瘤并改善患者的治疗效果。研究和开发投资将有助于将先进成像技术整合到肿瘤栓塞设备中。这包括结合即时显像模式，例如 MRI（磁振造影）和 CT（电脑断层扫描）扫描，以便在栓塞过程中更好地可视化肿瘤和周围组织。例如，根据美国数位行销公司WebFX的数据，医疗科技公司通常将年收益的5.1%用于研发计划。美国和英国医疗技术公司的研发支出增加了11.5%。因此，不断增加的研发费用推动了历史时期肿瘤栓塞器械市场的成长。

目录

第一章执行摘要

  • 肿瘤栓塞装置 - 市场吸引力与宏观经济格局

第二章 目录

第三章表格一览

第四章图表一览

第 5 章 报告结构

第六章市场特征

  • 一般市场定义
  • 概述
  • 肿瘤栓塞设备市场定义与细分
  • 市场区隔：按类型
    • 放射栓塞剂
    • 非放射性栓塞剂
  • 市场区隔：按应用
    • 癌症肿瘤
    • 非癌性肿瘤
  • 市场区隔：按最终用户
    • 医院
    • 癌症治疗中心
    • 门诊手术中心

第七章肿瘤栓塞器材市场：宏观经济情景

  • COVID-19 的影响：肿瘤栓塞器材市场
  • 乌克兰战争对肿瘤栓塞器材市场的影响
  • 高通膨的影响：肿瘤栓塞器械市场

第八章 主要市场趋势

  • 开发精确肿瘤栓塞的新系统或平台
  • 策略联盟和收购以推进肿瘤栓塞研究
  • 开发用于癌症治疗的临床实验药物
  • 临床试验推进肿瘤栓塞治疗
  • 增加资金支持创新抗癌药物的开发

第九章世界市场规模与成长

  • 市场规模
  • 2018-2023 年市场成长表现
    • 2018-2023年市场驱动因素
    • 2018-2023年市场限制因素
  • 市场成长预测，2023-2028，2033F
    • 2023-2028年市场驱动因素
    • 2023-2028年市场限制因素

第十章全球肿瘤栓塞器材市场：细分

  • 全球肿瘤栓塞器材市场：按类型分類的表现和预测，2018-2023、2028F、2033F
  • 全球肿瘤栓塞器材市场：按应用分類的表现与预测，2018-2023、2028F、2033F
  • 全球肿瘤栓塞设备市场：最终用户的表现和预测，2018-2023、2028F、2033F

第十一章肿瘤栓塞装置市场：区域与国家分析

  • 全球肿瘤栓塞器材市场：按地区分類的表现和预测，2018-2023、2028F、2033F
  • 全球肿瘤栓塞器械市场：按国家分類的表现和预测，2018-2023、2028F、2033F

第十二章亚太市场

第十三章西欧市场

第十四章 东欧市场

第十五章 北美市场

第十六章 南美洲市场

第十七章 中东市场

第十八章 非洲市场

第十九章 竞争格局及公司概况

  • 公司简介
  • Merit Medical Systems Inc.
    • 公司简介
    • 产品与服务
    • 经营策略
    • 财务概览
  • Siemens Healthineers AG
    • 公司简介
    • 产品与服务
    • 经营策略
    • 财务概览
  • Cook Medical LLC
    • 公司简介
    • 产品与服务
    • 财务概览
  • AngioDynamics Inc.
    • 公司简介
    • 产品与服务
    • 经营策略
    • 财务概览
  • Boston Scientific Corporation
    • 公司简介
    • 产品与服务
    • 经营策略
    • 财务概览

第20章 竞争基准化分析

第 21 章竞争对手仪表板

第二十二章 重大併购

  • MedTech Acquisition Corporation Acquired TriSalus Life Sciences
  • Grand Pharmaceutical Group Acquired BlackSwan Vascular
  • Boston Scientific Corporation Acquired Obsidio
  • Hologic Acquired Acessa Health
  • Terumo Corporation Acquired Quirem Medical

第23章机会与策略

  • 2028 年的全球市场：提供新机会的国家
  • 2028年的全球市场：提供新机会的细分市场
  • 2028 年全球市场：成长策略
    • 基于市场趋势的策略
    • 竞争策略

第24章肿瘤栓塞器械市场：结论与建议

  • 结论
  • 推荐
    • 产品
    • 地方
    • 价格
    • 晋升
    • 人们

第25章附录

简介目录
Product Code: o&s1102

Tumor embolization devices are specialized medical tools used in the process of embolization, a minimally invasive procedure that blocks blood vessels to prevent blood flow to cancerous tumors or other abnormal growths.

The tumor embolization devices market consists of sales, by entities (organizations, sole traders or partnerships), of tumor embolization devices that are crucial in the treatment of various types of tumors, both cancerous and non-cancerous, by delivering embolic agents directly to the site of the tumor.

The global tumor embolization devices market was valued at $1,143.18 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 4.0%.

Increased Research And Development Spending

Rising research and development spending in the medical sector drove the tumor embolization devices market in the historic period. Increased research and development funding allows for the exploration of novel materials and designs for tumor embolization devices. This results in the development of more efficient and effective devices that can better target and treat tumors, leading to improved patient outcomes. R&D investments can contribute to the integration of advanced imaging technologies into tumor embolization devices. This may include the incorporation of real-time imaging modalities, such as MRI (magnetic resource imaging) or CT (computed tomography) scans, providing better visualization of tumors and surrounding tissues during the embolization procedure. For instance, according to the WebFX a US-based digital marketing agency, medical technology companies generally allocate 5.1% of their yearly revenue towards research and development projects. R&D expenditures for MedTech businesses in the US and the UK increased by 11.5%. Therefore, the increased research and development spending drove the growth of the tumor embolization devices market during the historic period.

Development Of New Systems Or Platforms For Precise Tumor Embolization

Companies in the tumor embolization devices market are focusing on developing innovative systems or platforms for precise tumor embolization to strengthen their position in the market. For instance, in November 2023, Fluidx Medical Technology, a US-based medical device company, developing embolic material and other technologies, revealed information about their new ULTRA embolic platform, which is intended to make therapeutic embolization procedures safer, better and faster. The ULTRA platform is intended to meet the demands of patients requiring moderately distal to proximal tumor embolization. Additionally, in June 2022, Siemens Healthineers, a Germany-based medical technology company that provides healthcare solutions and services, introduced Artis, a new, ceiling-mounted icono ceiling angiography system for precise tumor embolization. The new Artis icono ceiling assists medical personnel in performing with an extremely high level of precision, by combining mechanical flexibility, high positioning accuracy and intelligent operations.

The global tumor embolization devices market is concentrated, with a few players operating in the market. The top ten competitors in the market made up 42.39% of the total market in 2022.

Tumor Embolization Devices Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global tumor embolization devices market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for tumor embolization devices? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The tumor embolization devices market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider tumor embolization devices market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by application and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the tumor embolization devices market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by application and by end user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard - Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for tumor embolization devices providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: Radio embolic Agents; Non-Radioactive Embolic Agents
  • 2) By Application: Cancer Tumors; Noncancerous Tumors
  • 3) By End User: Hospitals; Cancer Treatment Centers; Ambulatory Surgical Centers
  • Companies Mentioned: Merit Medical Systems Inc.; Siemens Healthineers AG; Medical LLC; Angio Dynamics Inc.; Boston Scientific Corporation
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; Canada; USA; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; tumor embolization devices indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Tumor Embolization Devices- Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Tumor Embolization Devices Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Radio embolic Agents
    • 6.4.2 Non-radioactive Embolic Agents
  • 6.5 Market Segmentation By Application
    • 6.5.1 Cancer Tumors
    • 6.5.2 Noncancerous Tumors
  • 6.6 Market Segmentation By End User
    • 6.6.1 Hospitals
    • 6.6.2 Cancer Treatment Centers
    • 6.6.3 Ambulatory Surgical Centers

7 Tumor Embolization Devices Market - Macro Economic Scenario

  • 7.1 COVID-19 Impact On The Tumor Embolization Devices Market
  • 7.2 Impact Of The War In Ukraine On The Tumor Embolization Devices Market
  • 7.3 Impact Of High Inflation On The Tumor Embolization Devices Market

8 Major Market Trends

  • 8.1 Development Of New Systems Or Platforms For Precise Tumor Embolization
  • 8.2 Strategic Collaborations And Acquisitions To Advance Tumor Embolization Research
  • 8.3 Development Of Investigational Products For Carcinoma Treatment
  • 8.4 Clinical Trials Are Advancing Tumor Embolization Therapy
  • 8.5 Increasing Funding To Support Development Of Innovative Cancer Therapeutics

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Tumor Embolization Devices Market Segmentation

  • 10.1 Global Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Tumor Embolization Devices Market, Regional and Country Analysis

  • 11.1 Global Tumor Embolization Devices Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Tumor Embolization Devices Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Tumor Embolization Devices Market: Country Analysis
  • 12.6 Summary
  • 12.7 China Market
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Tumor Embolization Devices Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Tumor Embolization Devices Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Tumor Embolization Devices Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Major Companies
  • 16.2 South America Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Tumor Embolization Devices Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Tumor Embolization Devices Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Tumor Embolization Devices Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Tumor Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Merit Medical Systems Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Siemens Healthineers AG
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Cook Medical LLC
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Financial Overview
  • 19.5 AngioDynamics Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Boston Scientific Corporation
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 MedTech Acquisition Corporation Acquired TriSalus Life Sciences
  • 22.2 Grand Pharmaceutical Group Acquired BlackSwan Vascular
  • 22.3 Boston Scientific Corporation Acquired Obsidio
  • 22.4 Hologic Acquired Acessa Health
  • 22.5 Terumo Corporation Acquired Quirem Medical

23 Opportunities And Strategies

  • 23.1 Global Tumor Embolization Devices Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Tumor Embolization Devices Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Tumor Embolization Devices Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Tumor Embolization Devices Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer